These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 10906625

  • 1. Pharmacology of ACE inhibitors versus AT1 blockers.
    Vaughan D.
    Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
    Johnston CI.
    Blood Press Suppl; 2000 Aug; 1():9-13. PubMed ID: 11059629
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive drugs and fibrinolytic function.
    Fogari R, Zoppi A.
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [Abstract] [Full Text] [Related]

  • 4. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X.
    Feldman R.
    Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 15; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7. The renin-angiotensin-aldosterone system and fibrinolysis.
    Felmeden DC, Lip GY.
    J Renin Angiotensin Aldosterone Syst; 2000 Sep 15; 1(3):240-4. PubMed ID: 11881031
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug 15; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE, McKinnie JJ, Greenberg SS, Giles TD.
    Prog Cardiovasc Dis; 1999 Aug 15; 41(4):265-300. PubMed ID: 10362349
    [Abstract] [Full Text] [Related]

  • 10. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
    Meyer P, Flammer J, Lüscher TF.
    Invest Ophthalmol Vis Sci; 1995 Mar 15; 36(3):555-62. PubMed ID: 7890486
    [Abstract] [Full Text] [Related]

  • 11. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK, Sodhi RK, Singh M.
    Life Sci; 2007 Aug 02; 81(8):615-39. PubMed ID: 17692338
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC, MacDonald TM.
    Int J Clin Pract; 1998 Oct 02; 52(7):475-81. PubMed ID: 10622089
    [Abstract] [Full Text] [Related]

  • 13. ACE inhibitor and AT1 antagonist stimulate duodenal HCO3- secretion mediated by a common pathway - involvement of PG, NO and bradykinin.
    Aihara E, Kagawa S, Hayashi M, Takeuchi K.
    J Physiol Pharmacol; 2005 Sep 02; 56(3):391-406. PubMed ID: 16204762
    [Abstract] [Full Text] [Related]

  • 14. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ, Agirbasli M, Vaughan DE.
    Hypertension; 1999 Aug 02; 34(2):285-90. PubMed ID: 10454455
    [Abstract] [Full Text] [Related]

  • 15. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP, Rumley A, Lowe GD, McMurray JJ.
    Thromb Haemost; 2001 Dec 02; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract] [Full Text] [Related]

  • 16. [Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology].
    Hauser AC, Hörl WH.
    Wien Med Wochenschr; 2001 Dec 02; 151(7-8):160-4. PubMed ID: 11450164
    [Abstract] [Full Text] [Related]

  • 17. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
    Soldner A, Spahn-Langguth H, Mutschler E.
    Pharmazie; 1996 Nov 02; 51(11):783-99. PubMed ID: 8985974
    [Abstract] [Full Text] [Related]

  • 18. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 May 02; 48(5):2321-6. PubMed ID: 17460297
    [Abstract] [Full Text] [Related]

  • 19. The renin-angiotensin system and cardiovascular disease.
    Hollenberg NK.
    Blood Press Suppl; 2000 May 02; 1():5-8. PubMed ID: 11059628
    [Abstract] [Full Text] [Related]

  • 20. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Schmeisser A, Soehnlein O, Illmer T, Lorenz HM, Eskafi S, Roerick O, Gabler C, Strasser R, Daniel WG, Garlichs CD.
    Biochem Biophys Res Commun; 2004 Dec 10; 325(2):532-40. PubMed ID: 15530425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.